Dangerous Drugs

Recent Posts in Dangerous Drugs Category

Blog Home
  • FDA Approves Safety Labeling Changes for Fluoroquinolones

    Posted By Maher Law Firm || 26-Jul-2016

    The U.S. Food and Drug Administration (FDA) has approved new safety labeling changes for a class of antibiotics called fluoroquinolones in order to enhance existing warnings about their link with a number of serious and potentially permanent side effects. The purpose of these antibiotics is to treat bacterial infection by killing bacteria or stopping its growth. While effective in this capacity, ...
    Continue Reading
  • Consumer Alert: Zofran Linked to Congenital Birth Defects

    Posted By Maher Law Firm || 22-Jul-2016

    More than 200 lawsuits have been filed across the U.S. against the maker of the pharmaceutical Zofran, the generic version of which is widely prescribed off-label for the purpose of alleviating morning sickness in pregnant women. The generic “ondansetron” has been linked with serious birth defects, including heart and kidney malformation, cleft palate, and neural tube defects. With the ...
    Continue Reading
  • The FDA Orders Changes to Labels of Fluoroquinolones

    Posted By Maher Law Firm || 17-May-2016

    According to a recent news report, the United States Food and Drug Administration has announced that changes will be made to labels of fluoroquinolones, which are antibacterial drugs. The changes will require drug manufacturers to provide updated box warnings and medication guides that explain to consumers that the side effects of such medications may seriously outweigh the benefits for ...
    Continue Reading
  • Attention Focuses on Potential Zofran-Related Birth Defects

    Posted By The Maher Law Firm || 16-Apr-2015

    With "safe and effective" drugs now available to help women suffering from nausea and vomiting during pregnancy, "there is no reason for women to be exposed to a drug of unproven maternal and fetal safety" such as Zofran, Dr. Gideon Koren writes in a recent medical journal article. The article by Dr. Koren, a Toronto physician who is considered one of the world's foremost ...
    Continue Reading
  • FDA Warns of Possible Risk of Strokes and Heart Attacks with Low T Products

    Posted By The Maher Law Firm || 3-Mar-2015

    The U.S. Food and Drug Administration (FDA) has ordered manufacturers of testosterone products - or "low T" products - to change their labels to clarify the approved uses of these medications and to add a warning about "possible increased risk of heart attacks and strokes" associated with these drugs. In a March 3, 2015 drug safety communication, the FDA states that it is ...
    Continue Reading
  • What Did the Former FDA Chief Say About Risperdal?

    Posted By The Maher Law Firm || 20-Feb-2015

    Johnson & Johnson's Janssen unit knew as far back as 2001 that Risperdal could cause breast growth in boys, the former head of the U.S. Food and Drug Administration (FDA) recently testified in the first case to go to trial against the manufacturer of the antipsychotic medication. Dr. David Kessler, a pediatrician who served as the FDA's commissioner between 1990-1997, testified that ...
    Continue Reading
  • Jury Returns $2.3 Million Verdict in Actos Bladder Cancer Case

    Posted By The Maher Law Firm || 16-Feb-2015

    A jury has returned a $2.3 million verdict in favor of a former teacher who claimed that the manufacturer of the Actos diabetes drug failed to properly warn doctors about the drug's risk of causing bladder cancer. It marks the fifth verdict to go against the manufacturer, Takeda Pharmaceutical Co. of Osaka, Japan, in an Actos bladder cancer lawsuit, Bloomberg reports. After deliberating for ...
    Continue Reading
  • Federal Judge Urges Bard to Settle Transvaginal Mesh Lawsuits

    Posted By The Maher Law Firm || 16-Jan-2015

    In December, a federal court judge made the "very rare" move of warning C.R. Bard Inc. that it could be facing financial ruin if it fails to settle thousands of defective transvaginal mesh lawsuits against the company. U.S. District Court Judge Joseph R. Goodwin made those remarks at a December 9 hearing in the U.S. District Court for the Southern District of West Virginia, where more ...
    Continue Reading
  • Court Allows Plaintiffs to Present Birth Defects Expert in Zoloft MDL

    Posted By The Maher Law Firm || 14-Jan-2015

    Plaintiffs suing Pfizer over claims that its Zoloft antidepressant medication caused their children to suffer birth defects can present a key expert witness thanks to a ruling by the judge overseeing Zoloft multidistrict litigation in the U.S. District Court for the Eastern District of Pennsylvania. On January 7, U.S. District Court Judge Cynthia M. Rufe ruled that the plaintiffs would be allowed ...
    Continue Reading
  • Study Finds Risperdal, Other Antipsychotics Raise Acute Kidney Injury Risk in Elderly

    Posted By The Maher Law Firm || 22-Dec-2014

    Researchers have found that the use of Risperdal and other atypical antipsychotic drugs on elderly patients may expose them to an increased risk of suffering acute kidney injury (AKI). As NPR reported earlier this month, the use of antipsychotic medications on elderly patients in nursing homes who are suffering from Alzheimer's disease and other forms of dementia is prevalent in the U.S., ...
    Continue Reading
  • Panel Orders Consolidation of Xarelto Federal Court Lawsuits

    Posted By The Maher Law Firm || 15-Dec-2014

    The U.S. Judicial Panel on Multidistrict Litigation (JPML) has ordered the consolidation of all federal court lawsuits filed against Johnson & Johnson's Janssen Pharmaceuticals Inc. unit and Bayer Corp. by those claiming to have suffered injuries after taking the prescription blood thinner, Xarelto. In an order issued Friday, the JPML chose the U.S. District Court for the Eastern District ...
    Continue Reading
  • Articles Looks at Parent's Decision on Whether to Start Child on Risperdal

    Posted By The Maher Law Firm || 26-Nov-2014

    The risk of her son experiencing unnatural breast growth was one of the many factors weighed by a mother recently portrayed by the New York Times as she decided whether to start her child on the Risperdal antipsychotic drug. In the article, " One Drug or 2? Parents See Risk but Also Hope," the Times examines the dilemma faced by the mother of a six-year-old child who was already taking ...
    Continue Reading
  • How Quickly Should Generic Drug Makers Update Labels?

    Posted By The Maher Law Firm || 15-Sep-2014

    If you use a generic drug, how do you know whether you are taking a medication that is known to be a potentially dangerous drug ? Are you sure you have all of the information about it that is available? A recent court case that may be taken up by the U.S. Supreme Court asks how fast a generic drug maker must act to update its label to match what is published about the equivalent brand-name ...
    Continue Reading
  • New FDA Website Opens Recall Database to Consumers

    Posted By The Maher Law Firm || 29-Aug-2014

    A new website that will make U.S. Food and Drug Administration (FDA) data more readily available online may make it easier for consumers to find out about potentially dangerous drugs and faulty medical devices being sold in the American marketplace. The openFDA website provides APIs (application programming interfaces) that make it easier to obtain raw data and datasets cached by the FDA. This ...
    Continue Reading
  • FDA Approves Mirena Warning Labels

    Posted By The Maher Law Firm || 27-Jun-2014

    The Mirena birth control device is at the center of numerous legal claims against the manufacturer, Bayer HealthCare Pharmaceuticals, Inc. These lawsuits allege, among other things, that women have suffered injuries resulting from the migration of the Mirena intrauterine device (IUD) from its intended location. Many lawsuits have been consolidated in the U.S. District Court for the Southern ...
    Continue Reading
  • Bacteria Levels Prompt Class I Recall of Fresenius Dialysis Product

    Posted By The Maher Law Firm || 17-Jun-2014

    The U.S. Food and Drug Administration (FDA) announced May 28 that Fresenius Medical Care North America's voluntary recall of 58 lots of NaturaLyte Liquid Bicarbonate Concentrate 6.4-liter bottles has been classified as a Class I recall due to concerns of potential bacterial contamination. According to the FDA, a Class I recall is "the most serious type of recall" and reserved for ...
    Continue Reading
  • Where Do You Get Your Vaginal Mesh Information?

    Posted By The Maher Law Firm || 6-Jun-2014

    With the Internet at your fingertips, it is easy to get information on a wide variety of subjects these days. However, there is little guarantee that much of the information you will find is high-quality, reliable or even accurate. As pointed out in two studies that were recently presented at the American Urological Association's (AUA) annual meeting in Orlando, a good example of this problem ...
    Continue Reading
  • More Information Needed About Potential Risks of 'Low T' Products

    Posted By The Maher Law Firm || 6-May-2014

    Testosterone therapy, or "low T," products such as AndroGel are prescribed for men who may have a below-normal testosterone level. These products are typically available in the form of skin patches, mouth patches, gels and injections. The manufacturers of these drugs tend to promise men who have low testosterone that they will have more energy, experience better moods and regain the ...
    Continue Reading
  • Acetaminophen Liver Dangers Lead to Discontinuation, Removal by FDA

    Posted By The Maher Law Firm || 2-Apr-2014

    Acetaminophen is one of the most common over-the-counter pain relievers in the U.S. It's also heavily prescribed by doctors and hospitals in the form of combination drugs. But mounting research has implicated higher dosages of acetaminophen in serious liver risks, leading the FDA and drug industry to begin pulling some drugs from pharmacy shelves. According to an announcement from the FDA, ...
    Continue Reading
  • Anti-Depressants and Pregnancy: A Mixed Bag of Warnings and Potential Risks

    Posted By The Maher Law Firm || 3-Mar-2014

    Recently, we blogged about a new meta-analysis that found an increased risk of heart defects in infants born to women who use anti-depressants known as SSRI's late in pregnancy. In fact, some anti-depressants can cause a range of birth defects if taken by women during pregnancy, though the risks aren't necessarily reflected by the classification by the Food and Drug Administration (FDA). ...
    Continue Reading
  • FDA Announces Investigation into Testosterone Drugs

    Posted By The Maher Law Firm || 25-Feb-2014

    The U.S. Food and Drug Administration (FDA) recently announced they would be investigating the safety of testosterone drugs after two studies indicated an increased risk of cardiovascular events among men taking the hormone. The agency cautioned men from abandoning their drug routine without consulting their physician first, and warned doctors to follow prescribing recommendations carefully. ...
    Continue Reading
  • Mothers' Use of Anti-Depressants Could Harm Newborns

    Posted By The Maher Law Firm || 24-Feb-2014

    Women undergoing the hormonal changes of pregnancy may struggle with depression. The decision to use anti-depressants to treat major depression should be made by the doctor and expectant mother with an understanding of the risks of the drugs. A recent meta-analysis shows that the popular class of anti-depressants known as SSRIs may be a dangerous choice for women who are expecting, because the ...
    Continue Reading
  • Drug Maker Had Research Showing Dangers of Pradaxa

    Posted By The Maher Law Firm || 13-Feb-2014

    Many prescription drugs come with a lengthy list of side effects and warnings. But one drug maker is being called out for failing to warn patients about some very specific risks that may have contributed to 1,000 deaths in recent years. Now, the maker of the blood thinner Pradaxa is facing thousands of lawsuits. Legal documents filed recently suggest some employees of the drug manufacturer ...
    Continue Reading
  • Antidepressant Lexapro Blamed For Newborn's Death

    Posted By The Maher Law Firm || 16-Jan-2014

    Antidepressants such as Prozac, Paxil and Zoloft have long been associated with birth defects. However, drug companies have been reluctant to warn pregnant mothers about these dangers, as any type of warning of increased risk of injury affects sales. A recently filed lawsuit against Forest Laboratories and its popular antidepressant drug, Lexapro, alleges that a pregnant mom was prescribed Lexapro ...
    Continue Reading
  • Antipsychotic Drug | Zyprexa | Possible Cause Of Death

    Posted By The Maher Law Firm || 20-Jun-2013

    Zyprexa (Olanzapine or Fluoxetine Symbyax) is an antipsychotic medication manufactured by Eli Lilly & Co. It was approved by the FDA (Food and Drug Administration) for the treatment of schizophrenia and bipolar disorder. Schizophrenia is a “mental disorder” characterized by a breakdown of thought processes and deficiencies of emotional responses. Bipolar Disorder is a mood disorder ...
    Continue Reading
  • 45 results found. Viewing page 1 of 2. Go to page 1 2   Next